Brentuximab Intravenous and Moxetumomab pasudotox
Determining the interaction of Brentuximab Intravenous and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-Moxetumomab Pasudotox-tdfk
- Brentuximab Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Brentuximab Intravenous-Moxifloxacin
- Brentuximab Intravenous-Moxifloxacin (Systemic)
- Brentuximab Intravenous-Moxifloxacin Hydrochloride
- Brentuximab Intravenous-Moxifloxacin Injection
- Moxetumomab pasudotox-Brentuximab vedotin
- Moxetumomab pasudotox-Breo Ellipta
- Moxetumomab pasudotox-Brethine
- Moxetumomab pasudotox-Brethine Subcutaneous
- Moxetumomab pasudotox-Bretylium
- Moxetumomab pasudotox-Bretylium Injection